Acorah Software Products - Accounts Production 14.5.601 false true false true No description of principal activity 4 September 2022 30 September 2023 30 September 2023 14334705 Mr M R Kabir iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14334705 2022-09-03 14334705 2023-09-30 14334705 2022-09-04 2023-09-30 14334705 frs-core:CurrentFinancialInstruments 2023-09-30 14334705 frs-bus:PrivateLimitedCompanyLtd 2022-09-04 2023-09-30 14334705 frs-bus:FilletedAccounts 2022-09-04 2023-09-30 14334705 frs-bus:Micro-entities 2022-09-04 2023-09-30 14334705 frs-bus:AuditExempt-NoAccountantsReport 2022-09-04 2023-09-30 14334705 frs-bus:Director1 2022-09-04 2023-09-30
Registered number: 14334705
KARM Pharma Ltd
Financial Statements
For the Period 4 September 2022 to 30 September 2023
Balance Sheet
Registered number: 14334705
30 September 2023
£
Fixed assets 1,459
Current assets 8,985
Creditors: Amounts Falling Due Within One Year (9,113 )
NET CURRENT LIABILITIES (128 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,331
Accruals and deferred income (670 )
NET ASSETS 661
CAPITAL AND RESERVES 661

Notes

1. General Information
KARM Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14334705 . The registered office is 113 Harewood Terrace, Southall, UB2 4JN.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr M R Kabir
Director
26th March 2024